Specific positive and negative effects of FLIP on cell survival in human prostate cancer

Keiji Shimada1, Mitsutoshi Nakamura, Syuichi Matsuyoshi

  • 1Department of Pathology, Nara Medical University School of Medicine, Nara, 634-8521, Japan.

Carcinogenesis
|March 16, 2006
PubMed

Insights

FLICE-like inhibitory protein (FLIP) has dual roles in prostate cancer. It promotes metastasis by stabilizing beta-catenin but enhances proteasome inhibitor-induced apoptosis via the Raf-1/p38 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • FLICE-like inhibitory protein (FLIP) role in cancer is complex.
  • Prostate cancer progression involves cell survival and invasion.
  • Proteasome inhibitors are investigated for cancer therapy.

Purpose of the Study:

  • To elucidate the multifaceted roles of FLIP in human prostate cancer.
  • To investigate FLIP's interaction with proteasome inhibitors and its impact on cell signaling.
  • To determine FLIP's contribution to prostate cancer metastasis and survival.

Main Methods:

  • Cell culture and treatment with proteasome inhibitor MG132.
  • Western blotting to assess protein levels and interactions (FLIP, beta-catenin, cyclin D1, Raf-1, p38).
  • Immunohistochemistry and in vitro assays for colony formation and invasion.
  • FLIP knockdown experiments.

Main Results:

  • MG132 induced G2/M arrest and apoptosis via p38 activation.
  • MG132 stabilized FLIP, enhancing Raf-1/p38 signaling and cytotoxicity.
  • Overexpressed FLIP inhibited beta-catenin ubiquitylation, increasing cyclin D1, colony formation, and invasion.
  • FLIP overexpression correlated with beta-catenin/cyclin D1 in metastatic cells.
  • FLIP knockdown reversed pro-metastatic effects.
  • FLIP reduction inhibited MG132-induced apoptosis.

Conclusions:

  • FLIP promotes prostate cancer metastasis by inhibiting beta-catenin proteasomal degradation.
  • FLIP mediates proteasome inhibitor-induced apoptosis through the Raf-1/p38 pathway.
  • FLIP is a potential therapeutic target, and proteasome inhibitors may benefit advanced prostate cancers overexpressing FLIP.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...